Search for Stocks Search for IPO Search for Indices

Customer Portal

EMI Card

Download

Offers

BAJAJ FINSERV DIRECT LIMITED

Open Your FREE Demat Account Now!

Apply Now

Fundamentals Financials Shareholding About Company Peer Comparison Latest News FAQs

Alpa Laboratories Ltd. Share Price

NSE

BSE

NSE : ALPA

BSE : 532878

Sector : Healthcare

N/A

indicator

1D

1M

3M

6M

1Y

5Y

empty graph

Price Summary

Previous Close	₹59.62
Day's Range	₹59.10 - ₹62.00
Open	₹62.00
52 Week Range	₹46.10 - ₹95.00
Volume	8,962
Market Cap	₹0.00

Previous Close	₹60.96
Day's Range	₹59.14 - ₹60.96
Open	₹60.00
52 Week Range	₹46.00 - ₹99.75
Volume	294
Market Cap	₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs)	5.34
Market Cap (₹ in Mn)	0.00
Dividend Yield(%)	0.00
Price/Earning (TTM)	28.86
TTM EPS (₹)	2.08
P/E Ratio	11.23
Book Value(₹)	0.67
PAT Margin (%)	17.34
Face Value (₹)	10.00
ROCE(%)	15.76

Trade Value ( ₹ in Lacs)	0.18
Market Cap (₹ in Mn)	0.00
Dividend Yield(%)	0.00
Price/Earning (TTM)	28.86
TTM EPS (₹)	2.08
P/E Ratio	11.23
Book Value(₹)	0.67
PAT Margin (%)	17.34
Face Value (₹)	10.00
ROCE(%)	15.76

Financials

Particulars	QTR FY (₹ in Millions)	Annual FY (₹ in Millions)
Net sales	191.11	1116.45
Expenses	N/A	N/A
PBT	117.75	258.41
Operating profit	0.0	0.0
Net profit	117.76	196.79

Shareholding Pattern

Promoters (% Holding)

57.19%

Mutual funds (% Holding)

0.00%

Non-Institution (% Holding)

42.39%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

0.35%

About Alpa Laboratories Ltd.

Founded	1988
Managing Director	Paresh Chawla
NSE Symbol	ALPA

Peer Comparision

Stocks Name	Market Cap (Cr)(₹)	Market Price (₹)	52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd.	4,40,397.93	1,868.00	1,548.00 - 1,548.00
Divi's Laboratories Ltd.	2,48,664.42	9,432.00	5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd.	1,82,738.23	4,968.00	3,480.60 - 3,480.60
Apollo Hospitals Enterprise Ltd.	1,26,102.74	8,940.00	6,696.50 - 6,696.50
Lenskart Solutions Ltd.	1,22,899.37	685.00	0.00 - 0.00
Zydus Lifesciences Ltd.	1,15,012.19	1,161.50	835.50 - 835.50
Cipla Ltd.	1,10,793.75	1,385.00	1,165.70 - 1,165.70
Laurus Labs Ltd.	1,05,644.55	2,018.00	823.10 - 823.10
Max Healthcare Institute Ltd.	1,02,684.23	1,064.50	903.00 - 903.00
Aurobindo Pharma Ltd.	99,828.06	1,717.20	1,066.80 - 1,066.80

Latest News

Sep

21

2026

EQUITY Posted on Sep 21^st 2026

Haleos Labs informs about closure of trading window

Haleos Labs has informed that ‘Trading Window’ for dealing in securities of the Company for Designated Persons and specified Connected Persons (including their Immediate relatives) of the Company and Subsidiary of the Company, shall remain closed with effect from October 1, 2026 till 48 hours after the declaration of financial results for quarter and half year ended sept 30, 2026, In terms of the ‘Code of Conduct for Prevention of Insider Trading’ of the Company. Date of the Board meeting for considering the unaudited financial results Of the Company for the quarter and half year ended September 30, 2026, will be informed separately in due course.

The above information is a part of company’s filings submitted to BSE.

Read More

Sep

21

2026

EQUITY Posted on Sep 21^st 2026

Cohance Lifesciences informs about update

Cohance Lifesciences has informed that the United States Food and Drug Administration (USFDA) inspected the Company’s API manufacturing facility at Jaggaiahpet, Andhra Pradesh, India (FEI No. 3005554260), from 14 September to 19 September 2026. The inspection concluded with the issuance of a Form FDA 483 containing five observations. The Company has initiated appropriate corrective and preventive actions (CAPA) and will submit its response within the stipulated timeline. The Company remains committed to quality and regulatory compliance.

The above information is a part of company’s filings submitted to BSE.

Read More

Sep

21

2026

EQUITY Posted on Sep 21^st 2026

Anlon Healthcare informs about incorporation of subsidiary

Pursuant to regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (‘SEBI Master Circular’), Anlon Healthcare has informed that ‘ANLON HEALTHCARE NIGERIA’ having Registration Number ‘9874492’ has been incorporated as a subsidiary of the Company, with effect from September 20, 2026. The relevant details pursuant to Schedule III of the Listing Regulations and additional details as required under the SEBI Master Circular for compliance with the provisions of the Listing Regulations by listed entities is annexed in Annexure - A.

The above information is a part of company’s filings submitted to BSE.

Read More

Sep

21

2026

EQUITY Posted on Sep 21^st 2026

Glenmark Pharmaceuticals informs about analyst meet

Pursuant to the Regulation 30 and Para A of Part A of Schedule III of the SEBI LODR, Glenmark Pharmaceuticals has informed that the company will be meeting Investor/Analyst (Participants) in PL Capital - Emerging Titans 2026 Conference on 29-09-2026. No unpublished price sensitive information is proposed to be shared during the meeting.

The above information is a part of company’s filings submitted to BSE.

Read More

Sep

21

2026

EQUITY Posted on Sep 21^st 2026

Coral Laboratories submits board meeting intimation

Coral Laboratories has informed pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, September 25, 2026, to consider and approve Cost Audit report for the financial year 2025-26; and any other business with the permission of chairman.

The above information is a part of company’s filings submitted to BSE.

Read More

Sign in to Unlock Offers!

STEP 1/2

Open Demat Account today!

Mobile Number

Enter mobile number

Frequently Asked Questions

What is the current share price of Alpa Laboratories Ltd. ?

The current share price of Alpa Laboratories Ltd. is ₹59.62 as of 2026-09-21.

What is the Market Cap of Alpa Laboratories Ltd. Share?

The market capitalisation of Alpa Laboratories Ltd. is ₹126.35 as of 2026-09-18.

What is a 1 year return for Alpa Laboratories Ltd. ?

The 1-year return of Alpa Laboratories Ltd. is -35.26% as of 2026-09-21.

What is the P/E Ratio of Alpa Laboratories Ltd. Share?

The P/E ratio of Alpa Laboratories Ltd. is 11.23 as of 2026-09-21.

What is the 52 Week High and Low of Alpa Laboratories Ltd. ?

The 52-week high and low of Alpa Laboratories Ltd. are ₹95.00 and ₹46.10, respectively, as of 2026-09-21.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.

STEP 1/2

Open a Demat Account today!

Mobile Number Enter Valid Mobile Number

Indices : Nifty 50 Nifty Bank Nifty Financial Services Nifty Next 50 Nifty Midcap 100 BSE Sensex India Vix

Stocks : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Home

Shopping

Loan Offers

My Accounts

Explore